Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

Sanofi's Chief Digital Officer Emmanuel Frenehard had a thought that he just couldn't shake: how can Sanofi extend the ...

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

Sanofi (SNY) has released an update. Don't Miss our Black Friday Offers: Sanofi’s Sarclisa received a positive recommendation from the EMA’s CHMP for treating newly diagnosed multiple myeloma patients ...

The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.

November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with ...

Innovation scale-up Wazoku is expanding into the GCC region, with the establishment of a dedicated presence in the United ...

Memphis-Shelby County Schools is suing multiple drug companies. Attorneys call it a mass action lawsuit, with nearly 100 ...

The Telangana government is set to launch an AI advisory council for the lifesciences sector by January 2025, aimed at ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

CHICAGO -- Electronic nudges increased uptake of flu vaccines among patients with a history of acute myocardial infarction ...